205.418.81008 Boehringer Ingelheim Investigational Site

Sapporo, Hokkaido

0 studies enrolling now · 1 studies all time

What they study most

Asthma

Studies at this site

• Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma I — Completed